CLL10 protocol of the German CLL-Study Group (GCLLSG). Phase III trial of

Bendamustine for Chronic Lymphocytic Leukaemia. Bendamustine in CLL NECN

first-line treatment for people with CLL. The technology. Bendamustine (brand

Following the German reunification, further studies with bendamustine resulted in

Bendamustine for first-line treatment in CLL. INDICATIONS. Bendamustine is

TREANDA® (bendamustine HCl) for Injection. Discover the elements of efficacy

Dec 21, 2011 . Bendamustine (Treanda) for CLL and NHL. Bendamustine HCl (Treanda -

Jun 15, 2011 . A closer look at Bendamustine in CLL. Have I been too hard on Bendamustine?

Mar 16, 2010 . Also, for your information, bendamustine was approved by the US Food and Drug

This is a controlled document and therefore must not be changed or photocopied.

Cytotoxicity of bendamustine towards B-CLL and normal mononuclear cells . To

Dec 10: In its Final Appraisal Determination, NICE has supported the use of

Bendamustine is an alkylating agent with properties of a purine analog and is a

The drug and its derivatives break down into alkyl groups. The alkyl groups bond

Treanda® and Rituxan® Effective Initial Therapy for CLL. According to the results

Efficacy of bendamustine in patients with relapsed or refractory chronic

Dec 15, 2007 . You can find any number of recent quasi-technical / PR reports on the subject of

Dec 17, 2008 . In a recent phase III trial of previously untreated patients with CLL, bendamustine

. chronic lymphocytic leukemia (CLL), acute myelocytic leukemia (AML), and .

decision by the US Food and Drug Administration regarding approval for its use

Apr 14, 2009 . Bendamustine (Treanda, Cephalon) was approved by the FDA in March 2008 for

Nov 7, 2010 . [31][Level of evidence: 1iiDiii] The German CLL Study Group is comparing

Nov 4, 2010 . For patients with CLL, bendamustine hydrochloride is administered as a 30

Bendamustine in combination with Rituximab (BR) for use in relapsed/refractory

1 day ago . The open-label, multi-center, active-controlled study is enrolling bendamustine-

In the first trial-a pivotal study of previously untreated CLL-bendamustine was

Jul 6, 2010 . Abstract and Introduction: This chemotherapeutic agent may be effective in

It will give you some information about chronic lymphocytic leukemia (CLL), how

Jan 10, 2006 . Bendamustine and Rituximab in Treating Patients With Relapsed Chronic

Treanda (bendamustine hydrochloride) newly approved drug information on .

and tolerability of bendamustine to chlorambucil (LeukeranŽ) in patients with

Bendamustine hydrochloride is an alkylating agent recently approved by the FDA

Bendamustine Combined With Rituximab in Patients With Relapsed and/or

1615 Retherapy with Bendamustine-Containing Regimens in Patients with

May 20, 2005 . Bendamustine was given at a dose of 90 mg/m2 as a 30-minute . in both the

Mar 17, 2011 . Bendamustine for previously treated CLL patients. This paper published in the

Has anyone tried Bendamustine for CLL? mikedout Registered Users. mikedout

Phase I/II trials with bendamustine as single-agent therapy in CLL have shown

of CLL and rituximab-refractory indolent non-Hodgkin's lymphoma. In a

Apr 12, 2010 . Bendamustine, a unique alkylating agent with purine analog properties, has

May 1, 2010 . In Phase II and III trials in patients with indolent NHL and CLL, bendamustine has

Dec 3, 2009 . 205 Bendamustine Combined with Rituximab (BR) in First-Line Therapy of

Dec 14, 2008 . (if that doesn't work, go to http://ash.confex.com/ash/2008/webprogram/start.html

In pre-treated CLL patients, impaired bone marrow function is likely to enhance

Apr 15, 2008 . The bendamustine application as a CLL treatment received priority review from

Nov 1, 2011 . It is used to treat a type of cancer of the white blood cells called chronic

Treanda (bendamustine hydrochloride). Company: Cephalon Approval Status:

Nov 25, 2009 . Unfortunately, CLL is considered incurable with the chemotherapeutic agents

Bendamustine was approved for the treatment of CLL on the basis of a

Mar 20, 2008 . The FDA has approved bendamustine (Treanda) to treat chronic lymphocytic

Sitemap